Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10201 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Theratechnologies Inc.

VITAS® Healthcare Promotes Four Leaders to Executive Team: Coronado, Cosma, De La Rosa, Hamrick

Read more ››
By: GlobeNewswire - 06 Feb 2024

Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals

Read more ››
By: GlobeNewswire - 06 Feb 2024

BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  BioVie Inc.

Iridex Corporation Receives European Patent on MicroPulse Technology

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  IRIDEX Corporation

KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  KALA BIO, Inc.

iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  iCAD, Inc.

Avalyn to Participate in Multiple Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 06 Feb 2024

Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Rentschler Biopharma SE | Rentschler Biopharma Inc. | Rentschler Biopharma Inc.

Cybrexa Regains Rights to CBX-12

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Cybrexa Therapeutics

Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Reviva Pharmaceuticals, Inc.

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Cue Biopharma, Inc.

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Sensus Healthcare, Inc.

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Seer, Inc.

Recludix Pharma to Present at Two Investor Conferences in February

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Recludix Pharma

electroCore Expands Intellectual Property Portfolio

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  electroCore, Inc.

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Unity Biotechnology Inc

NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today

Read more ››
By: GlobeNewswire - 06 Feb 2024

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Ovid Therapeutics Inc.

Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Read more ››
By: GlobeNewswire - 06 Feb 2024
Related companies:  Fulcrum Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑